Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.
You can get CME credit for this episode here!Click here for CME Account Creation Instructions
New guidelines have just been published on the care of family members of critically ill patients! So many family members of critically ill patients have significant problems, including PTSD and depression, in the months following the ICU stay of their loved one. Peter, Rob, Mike, and John review select recommendations of these new guidelines. Incredibly important content this month! Download Companion HandoutDownload You can get CME credit for this episode here! Click here for CME Account Creation Instructions ...
In this podcast we discuss the very controversial SSC 2018 Update. We know that sepsis is a time-sensitive illness, but does a 1-hour bundle make sense? Download Episode MaterialDownload ...
The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published. In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis. Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding. In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. Download Companion HandoutDownload You can get CME credit for this episode here!Click here for CME Account Creation Instructions ...
